Dittrich C, Graninger W, Lenzhofer R, Lochs H, Abel-Telkes B
Wien Klin Wochenschr. 1984 Sep 28;96(18):679-84.
An assessment was undertaken of the value of plasmapheresis in patients with circulating immune complexes and/or extraintestinal manifestations of Crohn's disease (arthritis, iridocyclitis, erythema nodosum, pyoderma gangrenosum, stomatitis, fever). In 17 patients aged 20 to 50 years (median 34 years) 46 plasmaphereses were performed using a continuous flow-cell separator. Before and after plasmaphereses the concentrations of circulating immune complexes, of complement C4, of the immunoglobulins IgG and IgM and of the proteins alpha-1-antitrypsin, CRP, prealbumin and beta-lipoprotein were determined. 71% of patients given plasmaphereses showed clinical remission of the extraintestinal manifestations and 85% demonstrated a reduction of circulating immune complexes. Clinical follow-up of the patients was documented by the Crohn's Disease Activity Index (CDAI), which was reduced by plasmaphereses to a highly significant degree (p less than 0.005). For patients displaying an acute phase of Crohn's disease with extraintestinal manifestations and/or circulating immune complexes plasmapheresis represents an effective mode of therapy, which, moreover, lacks serious side effects.
对患有循环免疫复合物和/或克罗恩病肠外表现(关节炎、虹膜睫状体炎、结节性红斑、坏疽性脓皮病、口腔炎、发热)的患者进行了血浆置换价值的评估。在17名年龄在20至50岁(中位数34岁)的患者中,使用连续流动细胞分离器进行了46次血浆置换。在血浆置换前后,测定了循环免疫复合物、补体C4、免疫球蛋白IgG和IgM以及α-1抗胰蛋白酶、CRP、前白蛋白和β-脂蛋白的浓度。接受血浆置换的患者中有71%出现肠外表现的临床缓解,85%显示循环免疫复合物减少。通过克罗恩病活动指数(CDAI)记录患者的临床随访情况,血浆置换使其显著降低(p小于0.005)。对于表现为伴有肠外表现和/或循环免疫复合物的克罗恩病急性期患者,血浆置换是一种有效的治疗方式,而且没有严重的副作用。